When Malcolm MacLeod made it his personal mission to update the results of every clinical trial ever registered at the University of Edinburgh, UK, he didn’t realize that the effort would take years.
The company confirmed the publication of its successful clinical case series in Frontiers in Immunology, a peer-reviewed scientific journal, and received confirmation from the U.S. Food and Drug ...
A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced publication in the Journal of Clinical Oncology showcasing data from its study of ...
Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell’s ...
A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...
The United States has some of the poorest health outcomes among high-income countries around the world, outcomes that are particularly striking for racial and ethnic minority groups and rural ...
First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...
EDMOND, Okla. – May 13, 2025 -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative solutions for women's pelvic health, today announced the peer-reviewed publication of ...
Clinical trial achieved all three primary objectives with no significant safety issues being reported Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results